Allarta’s technology is focused in three areas.

Proprietary Immune-Privileged Polymer Platform
Empowering
Safe, Durable, Retrievable Therapy

Next-Gen Microgels
Enabling
Therapeutic Cells & Medicines

RT-Vaccine Delivery Platform
Disrupting
Cold Chain Logistics
Proprietary platform

Our Technology Pipeline
